Fierce Biotech Homepage

blocks coins money
Pharma

Editor’s Corner: Why an AZ-BMS merger would be a very bad idea

A merger risks severe regulatory concerns, pipeline disruptions and layoffs, while damaging the broader biopharma ecosystem, argues Fierce's Angus Liu
Angus Liu Aug 3, 2026 12:25am
Madrigal CEO
Favicon Fierce Biotech

‘It’s making a difference’: Madrigal CEO talks MASH dealmaking

Aug 3, 2026 8:00am
Apple trees in an orchard
Favicon Fierce Biotech

BlossomHill eyes $112M IPO harvest to fund Tagrisso challenger

Aug 3, 2026 9:18am
Guido Oelkers Sobi BioNTech
Favicon Fierce Biotech

After 5-month wait, BioNTech reveals Sobi CEO will take top job

Aug 3, 2026 7:35am
MA
Favicon Fierce Biotech

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm
Boerner

BMS delays key Cobenfy, milvexian readouts amid Q2 beat

Jul 30, 2026 10:12am
More News
Fierce Biotech

Sanofi CEO ‘looking deeply’ at pipeline as clearout continues

Jul 30, 2026 3:27am

Legend Biotech CEO resigns; search underway for replacement

Jul 27, 2026 9:32am

Merck prepares expanded access to monthly PrEP pill early

Jul 24, 2026 10:40am
Fierce Biotech

Australia's Clinuvel to shed up to 20% of workforce in US move

Jul 23, 2026 5:47am